We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

James M. Beck

Reed Smith LLP

Legal Influencer

Q3 | 2018

Lexology Awards

The Lexology content marketing awards recognise authors that provide excellent content within a work area and region. Find out more

  • Q3 | 2018 in Healthcare and life sciences - US

Results 1 to 5 of 572
Most popular |Most recent

Biomaterials Access for the 21st Century

USA - November 12 2018 We’ve blogged several times about the Biomaterials Access Assurance Act of 1998, 21 U.S.C. 1601-06. In a nutshell, the BAAA provides suppliers of...

The Diagnostic Artificial Intelligence Speedbump Nobody’s Mentioning

USA - November 8 2018 The 21st Century Cures Act is noteworthy as the first legislative attempt at regulating artificial intelligence (“AI”) in the medical field. The Act...

Updating Our Post-Bauman 50-State Survey on General Jurisdiction by Consent

USA - November 5 2018 Not quite a year ago, we prepared a 50-state survey on the status of claims that a foreign corporation’s compliance with a state’s corporate...

Fosamax in U.S. Supreme Court - Justice Alito Un-Recuses

USA - November 1 2018 An unexpected bit of good news as we go into November. Bexis will be presenting at the Reed Smith annual client CLE program on big-deal pending cases...

On Prevention of Federal Fraud on the FDA Claims That Avoid Buckman

USA - October 29 2018 Private plaintiffs love to scream “fraud on the FDA”! Agency fraud is their magic potion for dissolving any FDA action that they don’t like. Just...